Authors: Ewesuedo, RB Wilson, LR Friedman, HS Moschel, RC Dolan, ME

Citation: Rb. Ewesuedo et al., Inactivation of O-6-alkylguanine-DNA alkyltransferase by 8-substituted O-6-benzylguanine analogs in mice, CANC CHEMOT, 47(1), 2001, pp. 63-69

Authors: Schilsky, RL Dolan, ME Bertucci, D Ewesuedo, RB Vogelzang, NJ Mani, S Wilson, LR Ratain, MJ

Citation: Rl. Schilsky et al., Phase I clinical and pharmacological study of O-6-benzylguanine followed by carmustine in patients with advanced cancer, CLIN CANC R, 6(8), 2000, pp. 3025-3031

Authors: Ewesuedo, RB Iyer, L Das, S Koenig, A Mani, S Vogelzang, NJ Schilsky, RL Brenckman, W Ratain, MJ

Citation: Rb. Ewesuedo et al., Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer, J CL ONCOL, 19(7), 2000, pp. 2084-2090

Authors: Friedman, HS Pluda, J Quinn, JA Ewesuedo, RB Long, L Friedman, AH Cokgor, I Colvin, OM Haglund, MM Ashley, DM Rich, JN Sampson, J Pegg, AE Moschel, RC McLendon, RE Provenzale, JM Stewart, ES Tourt-Uhlig, S Garcia-Turner, AM Herndon, JE Bigner, DD Dolan, ME

Citation: Hs. Friedman et al., Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma, J CL ONCOL, 18(20), 2000, pp. 3522-3528

Authors: Ewesuedo, RB Dolan, ME

Citation: Rb. Ewesuedo et Me. Dolan, Pharmacokinetics of oral O-6-benzylguanine and evidence of interaction with oral ketoconazole in the rat, CANC CHEMOT, 46(2), 2000, pp. 150-155